Evaluation of Adrenal Suppression of a Lipid Enhanced, Topical Emollient Cream Formulation of Hydrocortisone Butyrate 0.1% in Treating Children with Atopic Dermatitis

2007 ◽  
Vol 24 (1) ◽  
pp. 81-84 ◽  
Author(s):  
Lawrence Eichenfield ◽  
Charles N. Ellis ◽  
David Fivenson ◽  
Adelaide A. Hebert ◽  
Syd Dromgoole ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adrenal Suppression ◽  
Cream Formulation ◽  
Hydrocortisone Butyrate ◽  
Topical Emollient ◽  
Emollient Cream

Evaluation of “Steroid-Sparing” Effects of Xanthena® Cream in Patients with Mild to Moderate Atopic Dermatitis

2003 ◽  
Vol 1 (1) ◽  
pp. 39-42 ◽  
Author(s):  
N. Cassano ◽  
A. Amoruso ◽  
S. Masci ◽  
S. De Paola ◽  
S. Salvatori ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severity Score ◽  
Hydrocortisone Butyrate ◽  
Local Reactions ◽  
Steroid Sparing ◽  
Emollient Cream

Emollients play an important role in the management of atopic dermatitis (AD). The aim of this study was to evaluate the efficacy and the “steroid-sparing” activity of an emollient cream (Xanthena® cream) in patients with mild to moderate AD. Patients were asked to apply twice a day for 7 days a cream containing hydrocortisone butyrate on the lesionai skin and then to apply Xanthena® cream only on the left side of affected areas. During the 2-month study period, the use of the corticosteroid cream was resumed in case of flare-up in any side. The results obtained show significant differences of both the total severity score and the intensity of each symptom and sign of AD between the skin areas treated with Xanthena® cream and the control areas (P<0.05); a relevant reduction of steroid requirement was also noted in correlation with the use of this emollient cream (P<0.05). A significant improvement was observed even after the first month of therapy for most symptoms, except for excoriations/fissuring, oozing/crusting and burning which improved only at 2 months. Treatment was well-tolerated by the majority of patients; adverse local reactions, mostly transient and of mild intensity, were observed in 7% of cases.

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

2002 ◽  
Vol 109 (3) ◽  
pp. 547-555 ◽  
Author(s):  
Sakari Reitamo ◽  
Malcolm Rustin ◽  
Thomas Ruzicka ◽  
Frédéric Cambazard ◽  
Kirsti Kalimo ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adult Patients ◽  
Efficacy And Safety ◽  
Tacrolimus Ointment ◽  
Hydrocortisone Butyrate

scholarly journals Use of Mustela Stelatopia moisturising products in children with atopic dermatitis

2009 ◽  
Vol 6 (5) ◽  
pp. 87-90
Author(s):  
V A Revyakina ◽  
A T Surkov ◽  
S T Makarova ◽  
I I Balabolkin ◽  
V A Revyakina ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Comparison Group ◽  
Basic Group ◽  
Daily Application ◽  
Emollient Cream

THE AIM OF THE STUDY WAS To estimate the efficiency and tolerance of daily application of Mustela Stelatopia emollient cream and bath oil as products for care of child's skin in 64 children suffering from atopic dermatitis. Results. The study showed that Mustela Stelatopia had a considerable treatment-and-prophylactic effects resulted to lower dryness and reduced itching. Skin humidity and SCORAD index during the study had expressed positive dynamics in children of the basic group unlike the comparison group

Sign in / Sign up

Export Citation Format

Share Document